- Home
- SILO vs TCRT Comparison
SILO vs TCRT Comparison
Compare SILO & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- TCRT
- Stock Information
- Founded
- SILO 2010
- TCRT 1998
- Country
- SILO United States
- TCRT United States
- Employees
- SILO N/A
- TCRT N/A
- Industry
- SILO Apparel
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- TCRT Health Care
- Exchange
- SILO Nasdaq
- TCRT Nasdaq
- Market Cap
- SILO 4.5M
- TCRT 3.8M
- IPO Year
- SILO N/A
- TCRT N/A
- Fundamental
- Price
- SILO $0.60
- TCRT $5.02
- Analyst Decision
- SILO
- TCRT
- Analyst Count
- SILO 0
- TCRT 0
- Target Price
- SILO N/A
- TCRT N/A
- AVG Volume (30 Days)
- SILO 405.6K
- TCRT 48.5K
- Earning Date
- SILO 08-12-2025
- TCRT 08-13-2025
- Dividend Yield
- SILO N/A
- TCRT N/A
- EPS Growth
- SILO N/A
- TCRT N/A
- EPS
- SILO N/A
- TCRT N/A
- Revenue
- SILO $72,102.00
- TCRT $11,000.00
- Revenue This Year
- SILO $1.86
- TCRT $5,680,500.00
- Revenue Next Year
- SILO N/A
- TCRT N/A
- P/E Ratio
- SILO N/A
- TCRT N/A
- Revenue Growth
- SILO N/A
- TCRT 83.33
- 52 Week Low
- SILO $0.41
- TCRT $1.31
- 52 Week High
- SILO $4.50
- TCRT $6.99
- Technical
- Relative Strength Index (RSI)
- SILO 48.15
- TCRT 69.35
- Support Level
- SILO $0.60
- TCRT $4.72
- Resistance Level
- SILO $0.64
- TCRT $5.24
- Average True Range (ATR)
- SILO 0.04
- TCRT 0.52
- MACD
- SILO 0.01
- TCRT 0.02
- Stochastic Oscillator
- SILO 48.98
- TCRT 84.68
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.